AptarGroup found using ticker (ATR) have now 7 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 135 and 110 and has a mean target at 121.86. With the stocks previous close at 105.2 this now indicates there is a potential upside of 15.8%. There is a 50 day moving average of 105.22 and the 200 day MA is 111.69. The company has a market cap of $6,706m. Find out more information at: https://www.aptar.com [stock_market_widget type="chart" template="basic" color="green" assets="ATR" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $7,768m based on the market concensus. AptarGroup provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
→ Google Traductor
The following slide deck was published by AptarGroup, Inc.
→ Google Traductor
AptarGroup is a large manufacturer of containers for the medical sector and dispensers. Read why the company''s bonds may be a good investment.
→ Google Traductor
AptarGroup with ticker code (ATR) have now 7 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 135 and 110 with a mean TP of 121.86. With the stocks previous close at 104.41 this is indicating there is a potential upside of 16.7%. The day 50 moving average is 104.49 and the 200 moving average now moves to 113.48. The market cap for the company is $6,747m. Company Website: https://www.aptar.com [stock_market_widget type="chart" template="basic" color="green" assets="ATR" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $7,874m based on the market concensus. AptarGroup provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions.
→ Google Traductor
Hedi Tlili , Segment President at AptarGroup (NYSE: ATR ), reported a large insider sell on August 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Tlili sold 5,000 shares of AptarGroup . The total transaction amounted to $560,379. AptarGroup shares are trading down 0.52% at $111.33 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used primarily to make an … Full story available on Benzinga.com
→ Google Traductor
AptarGroup found using ticker (ATR) now have 7 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 135 and 110 calculating the average target price we see 121.86. With the stocks previous close at 109.63 this is indicating there is a potential upside of 11.2%. The day 50 moving average is 103.82 and the 200 day moving average is 114.39. The market cap for the company is $7,258m. Company Website: https://www.aptar.com [stock_market_widget type="chart" template="basic" color="green" assets="ATR" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $8,067m based on the market concensus. AptarGroup provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
→ Google Traductor
AptarGroup found using ticker (ATR) now have 7 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 135 and 110 with the average target price sitting at 121.86. Given that the stocks previous close was at 106.44 this would indicate that there is a potential upside of 14.5%. The 50 day moving average now sits at 103.61 while the 200 day moving average is 114.86. The market cap for the company is $6,903m. Company Website: https://www.aptar.com [stock_market_widget type="chart" template="basic" color="green" assets="ATR" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $7,903m based on the market concensus. AptarGroup provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
→ Google Traductor
New York , 2022-Aug-01 — /EPR Network/ — Global Pharmaceutical Packaging Market report from Global Insight Services is the single authoritative source of intelligence on Pharmaceutical Packaging [read full press release…]
→ Google Traductor
AptarGroup, Inc. (NYSE:NYSE:ATR) Q2 2022 Earnings Conference Call July 29, 2022 09:00 AM ET Company Participants Matt DellaMaria - Senior Vice President, Investor Relations &…
→ Google Traductor
The following slide deck was published by AptarGroup, Inc.
→ Google Traductor
AptarGroup Reports In-Line Q2 EPS
→ Google Traductor
(RTTNews) - AptarGroup Inc. (ATR) revealed earnings for its second quarter that increased from last year The company''s earnings came in at $63.63 million, or $0.95 per share. This compares with $55.28 million, or $0.81 per share, in last year''s second quarter. Excluding items, AptarGroup Inc. reported adjusted earnings of $64.31 million or $0.
→ Google Traductor
AptarGroup press release (NYSE:ATR): Q2 Non-GAAP EPS of $0.96 in-line.Revenue of $844.54M (+4.1% Y/Y) beats by $17.36M.
→ Google Traductor
AptarGroup (ATR) is scheduled to announce Q2 earnings results on Thursday, Jul. 28, after market close.The consensus EPS estimate is $0.96 (+5.5% Y/Y) and the consensus revenue estimate…
→ Google Traductor
Looking at the universe of stocks we cover at Dividend Channel, on 7/26/22, Fastenal Co. (Symbol: FAST), Cooper Companies, Inc. (Symbol: COO), and AptarGroup Inc. (Symbol: ATR) will all trade ex-dividend for their respective upcoming dividends. Fastenal Co. will pay its quarte
→ Google Traductor
AptarGroup (NYSE:ATR) declares $0.38/share quarterly dividend, in line with previous.Forward yield 1.51%Payable Aug.
→ Google Traductor
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar today declared a quarterly cash dividend of $0.38 per share.
→ Google Traductor
AptarGroup with ticker code (ATR) now have 7 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 167 and 125 with the average target price sitting at 137.57. With the stocks previous close at 103.11 this is indicating there is a potential upside of 33.4%. The day 50 moving average is 105.56 and the 200 moving average now moves to 116.84. The market cap for the company is $6,558m. Company Website: https://www.aptar.com [stock_market_widget type="chart" template="basic" color="green" assets="ATR" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $8,750m based on the market concensus. AptarGroup provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions.
→ Google Traductor
AptarGroup found using ticker (ATR) have now 7 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 167 and 125 with the average target price sitting at 140. With the stocks previous close at 98.93 this now indicates there is a potential upside of 41.5%. The 50 day MA is 107.99 and the 200 day MA is 117.78. The company has a market cap of $6,729m. Company Website: https://www.aptar.com [stock_market_widget type="chart" template="basic" color="green" assets="ATR" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $9,523m based on the market concensus. AptarGroup provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions.
→ Google Traductor
Aptar released its 2021 Corporate Sustainability / ESG Report entitled Better Takes Shape
→ Google Traductor
Opiant Pharmaceuticals (OPNT) on Wednesday said it would expand its long-term collaboration with Aptar Pharma for the making of Aptar''s nasal Unidose device to be used in the production…
→ Google Traductor
Long-term agreement includes a €2 million (approximately $2.1 million) investment by Opiant to expand Aptar’s production in support of OPNT003 Long-term agreement includes a €2 million (approximately $2.1 million) investment by Opiant to expand Aptar’s production in support of OPNT003
→ Google Traductor
Major players in the injection pen market are Novo Nordisk A/S , Ypsomed Holding AG, Sanofi, Eli Lilly and Company, Merck KGaA , AstraZeneca plc, F. Hoffmann-La Roche Ltd, Owen Mumford, Sulzer Ltd, Sun Pharmaceutical Industries Ltd, Pfizer, Lupin Ltd, Wockhardt Ltd, AptarGroup, Inc. Major players in the injection pen market are Novo Nordisk A/S , Ypsomed Holding AG, Sanofi, Eli Lilly and Company, Merck KGaA , AstraZeneca plc, F. Hoffmann-La Roche Ltd, Owen Mumford, Sulzer Ltd, Sun Pharmaceutical Industries Ltd, Pfizer, Lupin Ltd, Wockhardt Ltd, AptarGroup, Inc.
→ Google Traductor
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions announced today that
→ Google Traductor
Top Players Covered in the Prefilled Syringes Market Research Report are BD, Gerresheimer AG, AptarGroup, Inc., Helvoet Rubber & Plastic Technologies BV, West Pharmaceutical Services Inc., SCHOTT AG, Terumo Corporation, Nipro PharmaPackaging International and other key market players Top Players Covered in the Prefilled Syringes Market Research Report are BD, Gerresheimer AG, AptarGroup, Inc., Helvoet Rubber & Plastic Technologies BV, West Pharmaceutical Services Inc., SCHOTT AG, Terumo Corporation, Nipro PharmaPackaging International and other key market players
→ Google Traductor
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science, and YAT, a multi-functional, science-driven online skincare solutions company, have announced a strategic collaboration that aims to develop an innovative range of products and services for the skincare market. This partnership will bring together YATs unique consumer centric, product design and concept development capabilities and Aptar
→ Google Traductor
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions announced today that it has entered into exclusive negotiations with respect to a potential acquisition of all outstanding shares of Voluntis (ENXTPA: ALVTX), a pioneer in digital therapeutics. This acquisition would complement Aptars existing digital health portfolio of connected devices by adding digital therapeutic solutions a
→ Google Traductor
The proposed Aerosol Valves Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed
→ Google Traductor
AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions, released its 2020 Corporate Sustainability Report.
→ Google Traductor
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announces the launch of the company''s first fully recyclable mono-
→ Google Traductor
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announces the launch of the companys first fully recyclable mono-material pump for the beauty and personal care industries, called Future. Certified and Sustainable by Design In order to facilitate recycling, Future was designed using polyethylene (PE) mono-material only. Future is certified by Cyclos-HTP, the institute for Recyc
→ Google Traductor
AptarGroup, Inc. (NYSE: ATR ), a global leader in drug delivery, consumer product dispensing and active material science solutions, announced today that Candace Matthews has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210524005808/en/ Candace Matthews Joins Aptar Board of Directors Candace is a highly accomplished business leader with over 30 years of experience developing and marketing products for the healthcare, cosmetics, food and beverage industries. Candace currently serves as the Chief Reputation Officer for Amway, overseeing the company''s global reputation strategy and brand, along with its corporate social responsibility and enterprise sustainability program. Prior to this role, Candace was Amway''s Regional President of the Americas and before that, Chief Marketing Officer. With decades of international leadership experience, Candace has spent a significant amount of time in Asia, particularly in China, deeply immersing herself in the region and its cultures.
→ Google Traductor
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announced today that it has been named to 3BL Medias 100 Best Corporate Citizens ranking for its leadership and transparency in environmental, social and governance (ESG). 3BL Media evaluated the 1,000 largest public U.S. companies on ESG and Aptar is among the top 50 companies in this ranking. We are honored to be named among
→ Google Traductor
Comerica Bank trimmed its stake in shares of AptarGroup, Inc. (NYSE:ATR) by 3.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,737 shares of the industrial products companys stock after selling 1,183 shares during the quarter. Comerica Bank owned []
→ Google Traductor
AptarGroup, Inc. (NYSE:ATR) insider Marc Prieur sold 5,922 shares of the firms stock in a transaction that occurred on Friday, May 7th. The shares were sold at an average price of $157.47, for a total value of $932,537.34. Following the completion of the sale, the insider now directly owns 22,311 shares of the companys stock, []
→ Google Traductor
AptarGroup, Inc. (NYSE:ATR) insider Xiangwei Gong sold 1,393 shares of the companys stock in a transaction on Monday, May 10th. The stock was sold at an average price of $157.74, for a total transaction of $219,731.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through []
→ Google Traductor
Aptargroup Inc. (ATR) shares closed today at 0.5% below its 52 week high of $153.20, giving the company a market cap of $10B. The stock is currently up 11.9% year-to-date, up 45.3% over the past 12 months, and up 115.4% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 3.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -20.5% The company's stock price performance over the past 12 months lags the peer average by -28.2% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 142.5% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
→ Google Traductor
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material solutions, has again been named one of Barron’s 100 Most Sustainable Companies. Aptar is ranked number 76 for 2021 and this marks the third consecutive year Aptar has been included on Barron’s esteemed list. “We are honored to once again be included in Barron’s 100 Most Sustainable Companies and this is a testament to our steady progress on environ
→ Google Traductor
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR) today reported fourth quarter and annual results for 2020 and highlighted the resiliency of the Company’s business model throughout the COVID-19 pandemic. Fourth Quarter 2020 Summary Strong fourth quarter performance — reported sales grew 12%; core sales (excluding acquisitions and currency effects) grew 5% Double-digit sales growth for Pharma and Food + Beverage segments (reported and core sales) on broad based demand for our inn
→ Google Traductor
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has partnered with CARE®, a 501(c) organization who works around the globe to save lives, defeat poverty and achieve social justice. Through our on-going global partnership, Aptar will support CARE’s mission, including education programming, women’s economic empowerment efforts and CARE’s Crisis Response Campaign, by sponsoring the Fast
→ Google Traductor
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced that its Activ-Film™ technology was selected to protect a new SARS Rapid Antigen test for COVID-19 that recently received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). The QuickVue® SARS Antigen test is a point-of-care rapid antigen test developed by Quidel® Corporation, a leading manufact
→ Google Traductor
AptarGroup, Inc. , a global leader in drug delivery, consumer product dispensing and active packaging solutions, today declared a quarterly cash dividend of $0.36 per share. The payment date is… | January 14, 2021
→ Google Traductor
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, today declared a quarterly cash dividend of $0.36 per share. The payment date is February 17, 2021, to stockholders of record as of January 27, 2021. As previously announced, Aptar will hold a conference call on Friday, February 19, 2021 at 8:00 a.m. Central Time to discuss the Company’s fourth quarter and year-end results for 2020. The
→ Google Traductor
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has recently been recognized with Prime status by ISS ESG, one of the world’s leading rating agencies for sustainable investments. The ISS ESG Corporate Rating considers Environmental, Social and Governance (“ESG”) practices by evaluating more than 100 industry specific indicators. Companies are categorized as Prime if their ESG perform
→ Google Traductor
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has been recognized for its leadership in corporate sustainability by the global environmental non-profit CDP, securing a place on its prestigious ‘A List’ for tackling climate change. Aptar was recognized for its actions to cut emissions, mitigate climate risks and further the low-carbon economy, based on the data reported by the Compa
→ Google Traductor
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has been named one of “America’s Most Responsible Companies 2021” by Newsweek and is ranked in the top 100 among 400 U.S. companies. “We are extremely proud to be recognized by Newsweek and Statista for the second year in a row for our efforts to further a more sustainable, socially responsible, diverse, equitable and inclusive company,
→ Google Traductor
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR) a global leader in drug delivery, consumer product dispensing and active packaging solutions, has been named one of the “Most Responsible Companies in France” by Le Point. Aptar ranks in the top 100 companies for its efforts in the areas of Environment, Social and Governance (ESG) and in the top 50 companies in the Environment category. Le Point, a renowned French news magazine, joined forces with Statista, an independent data and
→ Google Traductor
Crystal Lake, Illinois, January 2, 2020 - AptarGroup, Inc. , a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced the dates and times… | January 2, 2020
→ Google Traductor
Crystal Lake, Illinois, October 31, 2019 - AptarGroup, Inc. , a global leader in consumer dispensing, active packaging and drug delivery solutions, today reported its third quarter… | October 31, 2019
→ Google Traductor
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter of 2018. Trends reversed 180 degrees during the first half of 2019 amid Powell's pivot and optimistic expectations towards a trade deal with China. Hedge funds and institutional
→ Google Traductor